At the Intersection of Biomaterials and Gene Therapy: Progress in Non-viral Delivery of Nucleic Acids.

T-cell therapy biomaterials gene medicine mRNA nanoparticle nucleic acid delivery pDNA delivery siRNA

Journal

Frontiers in bioengineering and biotechnology
ISSN: 2296-4185
Titre abrégé: Front Bioeng Biotechnol
Pays: Switzerland
ID NLM: 101632513

Informations de publication

Date de publication:
2019
Historique:
received: 20 03 2019
accepted: 15 05 2019
entrez: 20 6 2019
pubmed: 20 6 2019
medline: 20 6 2019
Statut: epublish

Résumé

Biomaterials play a critical role in technologies intended to deliver therapeutic agents in clinical settings. Recent explosion of our understanding of how cells utilize nucleic acids has garnered excitement to develop a range of older (e.g., antisense oligonucleotides, plasmid DNA and transposons) and emerging (e.g., short interfering RNA, messenger RNA and non-coding RNAs) nucleic acid agents for therapy of a wide range of diseases. This review will summarize biomaterials-centered advances to undertake effective utilization of nucleic acids for therapeutic purposes. We first review various types of nucleic acids and their unique abilities to deliver a range of clinical outcomes. Using recent advances in T-cell based therapy as a case in point, we summarize various possibilities for utilizing biomaterials to make an impact in this exciting therapeutic intervention technology, with the belief that this modality will serve as a therapeutic paradigm for other types of cellular therapies in the near future. We subsequently focus on contributions of biomaterials in emerging nucleic acid technologies, specifically focusing on the design of intelligent nanoparticles, deployment of mRNA as an alternative to plasmid DNA, long-acting (integrating) expression systems, and

Identifiants

pubmed: 31214586
doi: 10.3389/fbioe.2019.00131
pmc: PMC6558074
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

131

Références

Cell. 2017 Dec 14;171(7):1471
pubmed: 29245005
Mol Ther. 2008 Feb;16(2):359-69
pubmed: 18071335
Mol Cancer Ther. 2006 Sep;5(9):2428-34
pubmed: 16985077
Cancer Discov. 2017 Jul;7(7):656-657
pubmed: 28500027
Nat Rev Cancer. 2003 Jan;3(1):35-45
pubmed: 12509765
Mol Biotechnol. 2015 Aug;57(8):767-80
pubmed: 25997599
Hum Gene Ther. 2017 Oct;28(10):862-874
pubmed: 28826232
Cell. 1990 Nov 2;63(3):601-8
pubmed: 2225067
J Control Release. 2017 Jun 28;256:153-169
pubmed: 28450205
Curr Gene Ther. 2014;14(4):309-29
pubmed: 25039613
Biomacromolecules. 2017 Dec 11;18(12):3913-3923
pubmed: 29059529
Mol Cells. 2018 Aug 31;41(8):717-723
pubmed: 30110720
ACS Omega. 2018 May 31;3(5):5273-5280
pubmed: 30023914
BMC Biotechnol. 2008 Feb 29;8:23
pubmed: 18312664
Nucleic Acids Res. 2017 Apr 20;45(7):4021-4035
pubmed: 27928058
J Clin Invest. 2008 Sep;118(9):3132-42
pubmed: 18688285
Nat Biotechnol. 2015 Jan;33(1):97-101
pubmed: 25503382
Front Immunol. 2018 Nov 28;9:2798
pubmed: 30546367
Nat Immunol. 2002 Nov;3(11):999-1005
pubmed: 12407407
Mol Cell. 2014 Oct 2;56(1):55-66
pubmed: 25242144
Chem Biol. 2000 May;7(5):345-54
pubmed: 10801471
Mol Ther Nucleic Acids. 2018 Sep 7;12:504-517
pubmed: 30195787
Cell Death Differ. 2017 Feb;24(2):357-370
pubmed: 27886165
Biomaterials. 2017 Sep;140:58-68
pubmed: 28628776
Sci Transl Med. 2012 May 2;4(132):132ra53
pubmed: 22553251
N Engl J Med. 1988 Dec 22;319(25):1676-80
pubmed: 3264384
Blood. 2016 Jun 30;127(26):3312-20
pubmed: 27207800
Biomaterials. 2018 Jan;150:162-170
pubmed: 29031816
Biomaterials. 2019 Mar;195:100-110
pubmed: 30623788
Sci Rep. 2018 Oct 24;8(1):15732
pubmed: 30356111
Mol Ther Nucleic Acids. 2016 Jul 19;5(7):e337
pubmed: 27434682
Mol Cell. 2017 Apr 6;66(1):22-37.e9
pubmed: 28344082
Nano Lett. 2018 Nov 14;18(11):6655-6659
pubmed: 30185039
Nat Rev Genet. 2010 Sep;11(9):636-46
pubmed: 20717154
J Control Release. 2018 Dec 28;292:256-276
pubmed: 30312721
Pharmacol Rev. 2000 Dec;52(4):493-511
pubmed: 11121508
J Clin Invest. 2016 Sep 1;126(9):3363-76
pubmed: 27482888
Nat Nanotechnol. 2017 Aug;12(8):813-820
pubmed: 28416815
Sci Transl Med. 2013 Oct 30;5(209):209ra152
pubmed: 24174328
Mol Pharm. 2013 Mar 4;10(3):1070-9
pubmed: 23421924
Nucleic Acids Res. 2006 Jul 19;34(12):3577-84
pubmed: 16855294
Nat Genet. 2000 May;25(1):35-41
pubmed: 10802653
Acta Biomater. 2013 Jul;9(7):7429-38
pubmed: 23542234
Proc Natl Acad Sci U S A. 2018 May 8;115(19):4903-4908
pubmed: 29686087
ACS Nano. 2014 Mar 25;8(3):2252-60
pubmed: 24564881
J Virol. 2002 Jul;76(13):6545-57
pubmed: 12050367
Nat Nanotechnol. 2019 Mar;14(3):287-297
pubmed: 30692673
J Am Chem Soc. 2018 Nov 28;140(47):16264-16274
pubmed: 30346764
Nat Biotechnol. 2018 Feb;36(2):160-169
pubmed: 29334370
Nat Nanotechnol. 2018 Mar;13(3):214-219
pubmed: 29379205
Lancet. 2011 Aug 13;378(9791):595-605
pubmed: 21784508
Biomaterials. 2017 May;125:81-89
pubmed: 28231510
J Immunol. 2018 Feb 15;200(4):1255-1260
pubmed: 29330322
Leuk Lymphoma. 2014 May;55(5):999-1006
pubmed: 23885836
Biomacromolecules. 2018 Nov 12;19(11):4193-4206
pubmed: 30222931
Angew Chem Int Ed Engl. 2015 Oct 5;54(41):12029-33
pubmed: 26310292
Trends Biotechnol. 2013 Jul;31(7):397-405
pubmed: 23664777
Adv Healthc Mater. 2018 Oct;7(20):e1701153
pubmed: 29356400
Gene Ther. 1997 Jan;4(1):45-54
pubmed: 9068795
Nat Rev Immunol. 2018 Oct;18(10):605-616
pubmed: 30046149
Mol Ther Methods Clin Dev. 2016 Dec 31;4:92-101
pubmed: 28344995
Biomacromolecules. 2019 Jan 14;20(1):435-442
pubmed: 30525500
Biomaterials. 2015 May;50:67-74
pubmed: 25736497
J Control Release. 2015 Nov 28;218:22-8
pubmed: 26415855
J Control Release. 2019 Sep 28;310:141-154
pubmed: 31430499
Leuk Res. 2014 Nov;38(11):1299-308
pubmed: 25262448
Nat Biotechnol. 2011 Feb;29(2):154-7
pubmed: 21217696
J Control Release. 2016 Oct 10;239:137-48
pubmed: 27586186
Gene Ther. 2018 Dec;25(8):556-567
pubmed: 30242259
Nucleic Acids Res. 2008 May;36(9):e49
pubmed: 18411205
Genes (Basel). 2017 Feb 10;8(2):
pubmed: 28208635
Angew Chem Int Ed Engl. 2012 Oct 22;51(43):10751-5
pubmed: 22907668
Mol Med Today. 1999 Apr;5(4):178-86
pubmed: 10203751
Proc Natl Acad Sci U S A. 2017 Jan 24;114(4):E448-E456
pubmed: 28069945
Trends Genet. 2017 Nov;33(11):852-870
pubmed: 28964527
J Biotechnol. 2011 Oct 10;155(4):377-86
pubmed: 21816183
Proc Natl Acad Sci U S A. 1997 Sep 16;94(19):10122-7
pubmed: 9294173
J Transl Med. 2010 Oct 26;8:104
pubmed: 20977748
Leukemia. 2017 Jan;31(1):186-194
pubmed: 27491640
Biomaterials. 2009 Oct;30(28):5143-55
pubmed: 19540582
Tissue Eng Part A. 2019 Jan;25(1-2):131-144
pubmed: 30009674
Nano Lett. 2017 Feb 8;17(2):821-826
pubmed: 28122453
J Immunother. 2015 Apr;38(3):127-35
pubmed: 25751502
Nucleic Acids Res. 2011 Dec;39(22):e155
pubmed: 21984476
J Control Release. 2016 Feb 28;224:8-21
pubmed: 26742943
Virol J. 2014 Jun 13;11:111
pubmed: 24927852
Cell. 2017 Feb 9;168(4):724-740
pubmed: 28187291
Chem Sci. 2017 Aug 1;8(8):5705-5712
pubmed: 28989610
Gene Ther. 2004 Sep;11(18):1363-9
pubmed: 15295618
Clin Mater. 1992;9(3-4):179-87
pubmed: 10149968
Nat Methods. 2009 Jun;6(6):415-22
pubmed: 19478801
Ann Neurol. 2016 Feb;79(2):257-71
pubmed: 26573217
Proc Natl Acad Sci U S A. 1979 Mar;76(3):1274-8
pubmed: 286310
J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Aug 1;9(4):349-58
pubmed: 7541291
Biomacromolecules. 2014 Jul 14;15(7):2656-62
pubmed: 24890220
Gene Ther. 2005 Mar;12(5):418-26
pubmed: 15647766
Nat Nanotechnol. 2012 Jun 03;7(6):389-93
pubmed: 22659608
Curr Genomics. 2010 Apr;11(2):115-28
pubmed: 20885819
Cell Res. 2017 May;27(5):626-641
pubmed: 28281539
Nat Commun. 2017 Aug 30;8(1):389
pubmed: 28855514
Br J Clin Pharmacol. 2016 Sep;82(3):659-72
pubmed: 27111518
Nucleic Acids Res. 2003 Apr 1;31(7):1935-43
pubmed: 12655010
Eur J Pharm Sci. 2013 Jan 23;48(1-2):259-71
pubmed: 23142634
Biomacromolecules. 2019 Feb 11;20(2):854-870
pubmed: 30608149
Chem Rev. 2007 Sep;107(9):3715-43
pubmed: 17715981
Wiley Interdiscip Rev RNA. 2018 May;9(3):e1466
pubmed: 29383855
Mol Ther. 2018 Apr 4;26(4):1137-1153
pubmed: 29503198
Biomacromolecules. 2019 Feb 11;20(2):916-926
pubmed: 30571914
Cancer Res. 2017 May 1;77(9):2339-2350
pubmed: 28249903
Cell Reprogram. 2012 Apr;14(2):130-7
pubmed: 22339198
Nat Methods. 2008 Feb;5(2):135-46
pubmed: 18235434
J Cell Mol Med. 2007 May-Jun;11(3):521-30
pubmed: 17635643
RNA. 1997 Jun;3(6):677-87
pubmed: 9174101
Nat Nanotechnol. 2014 Aug;9(8):639-47
pubmed: 25086604
J Immunother. 2004 Sep-Oct;27(5):405-18
pubmed: 15314550
Nucleic Acids Res. 2002 Sep 15;30(18):4001-8
pubmed: 12235384
Drug Deliv. 2018 Nov;25(1):1234-1257
pubmed: 29801422
J Am Chem Soc. 2012 Jan 25;134(3):1376-91
pubmed: 22229439
Nat Med. 2018 May;24(5):563-571
pubmed: 29713085
Hum Gene Ther. 2017 Nov;28(11):1087-1104
pubmed: 28920716
RNA. 2003 Oct;9(10):1254-63
pubmed: 13130139
J Control Release. 2018 Jul 28;282:140-147
pubmed: 29518467
Science. 2015 Apr 3;348(6230):74-80
pubmed: 25838376
Stem Cells Dev. 2017 Jan 1;26(1):25-34
pubmed: 27676276
Biomark Res. 2017 Jun 24;5:22
pubmed: 28652918
J Control Release. 2013 Dec 10;172(2):426-35
pubmed: 23770010
Gene Ther. 2017 Jan;24(1):31-39
pubmed: 27824330
N Engl J Med. 2011 Nov 3;365(18):1673-83
pubmed: 22047558
Chem Rev. 2017 Aug 9;117(15):9874-9906
pubmed: 28640612
Mol Ther. 2004 Aug;10(2):365-72
pubmed: 15294183
Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):3606-10
pubmed: 10097084
Nucleic Acid Ther. 2017 Oct;27(5):251-259
pubmed: 28796573
Adv Mater. 2016 Oct;28(40):8912-8920
pubmed: 27558441
Mol Pharm. 2017 Jul 3;14(7):2422-2436
pubmed: 28597662
Mol Ther. 2017 Feb 1;25(2):356-367
pubmed: 28153088
Proc Natl Acad Sci U S A. 2013 Feb 5;110(6):2082-7
pubmed: 23341631
Pharmaceuticals (Basel). 2018 Oct 18;11(4):
pubmed: 30340426
RNA Biol. 2017 Mar 4;14(3):361-369
pubmed: 28080204
Nat Commun. 2017 Jun 28;8:15939
pubmed: 28656978
Immunity. 1995 Jul;3(1):39-50
pubmed: 7542548
Mol Ther. 2002 Jul;6(1):30-4
pubmed: 12095300
J Immunother. 2009 Feb-Mar;32(2):169-80
pubmed: 19238016
J Vis Exp. 2013 Nov 07;(81):e50980
pubmed: 24300077
J Clin Invest. 2017 Jun 1;127(6):2176-2191
pubmed: 28436934
Nucleic Acids Res. 2011 Apr;39(7):2981-94
pubmed: 21149259
Blood. 2018 Sep 6;132(10):1022-1026
pubmed: 29925499
J Biotechnol. 2012 Mar 31;158(1-2):44-9
pubmed: 22285955
Discov Med. 2010 Apr;9(47):277-88
pubmed: 20423671
Science. 2014 Nov 28;346(6213):1258096
pubmed: 25430774
Diseases. 2018 May 21;6(2):
pubmed: 29883422
Proc Natl Acad Sci U S A. 2018 Apr 24;115(17):4340-4344
pubmed: 29632214
Gene Ther. 2006 Jan;13(1):95-100
pubmed: 16177816
Mol Cell. 2017 Apr 6;66(1):9-21.e7
pubmed: 28344080
Mol Ther. 2016 Sep;24(9):1513-27
pubmed: 27377044
Cancer Lett. 2017 Mar 1;388:208-219
pubmed: 27986464
Science. 1992 Jul 10;257(5067):238-41
pubmed: 1352912
Nat Mater. 2011 Mar;10(3):243-51
pubmed: 21336265
Blood. 2016 Nov 3;128(18):2206-2217
pubmed: 27554082
Proc Natl Acad Sci U S A. 1991 Apr 1;88(7):2726-30
pubmed: 2011582
Hum Gene Ther Methods. 2015 Aug;26(4):134-46
pubmed: 26222896
Nat Biotechnol. 2015 Jan;33(1):64-72
pubmed: 25485616
Adv Drug Deliv Rev. 2017 Jun 1;115:115-154
pubmed: 28778715
Proc Natl Acad Sci U S A. 2006 Oct 10;103(41):15008-13
pubmed: 17005721
Nat Med. 2000 Dec;6(12):1406-10
pubmed: 11100129
Proc Natl Acad Sci U S A. 1989 Aug;86(16):6077-81
pubmed: 2762315
J Mater Chem B. 2015 May 21;3(19):3972-3982
pubmed: 32262619
Biosci Rep. 2017 Dec 5;37(6):
pubmed: 29089466
Methods Mol Biol. 2017;1499:193-200
pubmed: 27987151
Nano Lett. 2012 Jul 11;12(7):3867-71
pubmed: 22725653
Nat Med. 2002 Jan;8(1):47-53
pubmed: 11786906
J Mater Chem B. 2017 Sep 21;5(35):7238-7261
pubmed: 32264174
Int J Nanomedicine. 2013;8:2985-95
pubmed: 23990717
J Exp Med. 1955 Aug 1;102(2):157-77
pubmed: 13242741
Int J Mol Sci. 2018 Apr 27;19(5):
pubmed: 29702615
Biomaterials. 2004 Aug;25(19):4709-18
pubmed: 15120517
Mol Ther. 2008 Apr;16(4):765-72
pubmed: 18334990
FASEB J. 1993 Aug;7(11):1061-9
pubmed: 8370477
Annu Rev Immunol. 1992;10:835-73
pubmed: 1591005
J Immunol. 2008 Sep 1;181(5):2990-8
pubmed: 18713969
Curr Opin Mol Ther. 2001 Jun;3(3):229-34
pubmed: 11497345
Nat Rev Immunol. 2018 Mar;18(3):212-219
pubmed: 28853444
PLoS One. 2016 Sep 02;11(9):e0161955
pubmed: 27588424
Biomaterials. 2016 May;87:131-146
pubmed: 26923361
EMBO Mol Med. 2018 Nov;10(11):
pubmed: 30224381
J Biomed Mater Res B Appl Biomater. 2019 Aug;107(6):1824-1832
pubmed: 30466196
Mol Ther Nucleic Acids. 2014 May 27;3:e165
pubmed: 24892724

Auteurs

Hasan Uludag (H)

Department of Chemical and Materinals Engineering, University of Alberta, Edmonton, AB, Canada.
Department of Biomedical Engineering, University of Alberta, Edmonton, AB, Canada.
Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB, Canada.

Anyeld Ubeda (A)

Department of Biomedical Engineering, University of Alberta, Edmonton, AB, Canada.

Aysha Ansari (A)

Department of Chemical and Materinals Engineering, University of Alberta, Edmonton, AB, Canada.

Classifications MeSH